KIORA PHARMACEUTICALS, INC. (KPRX)

Import this data to Google Sheets with:

=jivedata("KPRX","financials")

Full statements spill as a table. For one cell: =jivedata("KPRX","Revenue") or =jivedata("KPRX","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

KIORA PHARMACEUTICALS, INC.

KPRX • CIK 0001372514

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$2,454.684	$3,792.322	$8,696.57	$7,076.533
Short-term Investments	—	$22,999.76	$8,392.513	$9,761.994
Prepaid Expense and Other Assets, Current	$233.382	$2,042.487	$1,141.804	$1,127.482
Assets	$13,711.87	$36,484.484	$24,253.3	$23,776.09
Accounts Receivable, after Allowance for Credit Loss, Current	—	$601.197	$1,522.77	$1,091.385
Assets, Current	$4,738.031	$29,706.012	$21,748.448	$21,262.515
Property, Plant and Equipment, Net	$8.065	$5.232	$91.672	$99.637
Restricted Cash and Cash Equivalents, Noncurrent	$4.267	$4.057	$4.566	$4.706
Intangible Assets, Net (Excluding Goodwill)	$8,813.85	$6,687.1	$2,063.1	$2,063.1
Liabilities	$7,602.216	$10,724.708	$8,126.764	$6,919.401
Operating Lease, Right-of-Use Asset	$106.89	$57.17	$285.827	$260.753
Other Assets, Noncurrent	$40.767	$24.913	$59.687	$85.379
Accounts Payable, Current	$206.26	$415.59	$1,060.306	$216.497
Accrued Liabilities, Current	$1,380.666	$4,588.657	$2,406.731	$1,981.573
Operating Lease, Liability, Current	$47.069	$23.355	$164.461	$172.425
Liabilities, Current	$1,633.995	$6,008.713	$3,631.498	$2,370.495
Business Combination, Contingent Consideration, Liability, Noncurrent	$5,128.959	$4,191.49	$2,939.316	$3,036.157
Deferred Income Tax Liabilities, Net	$779.44	$490.69	$102.152	$102.152
Contract with Customer, Liability, Noncurrent	—	—	$1,250	$1,250
Operating Lease, Liability, Noncurrent	$59.822	$33.815	$203.798	$160.597
Liabilities, Noncurrent	$5,968.221	$4,715.995	$4,495.266	$4,548.906
Preferred Stock, Value, Issued	$0.004	$0.004	$0.004	$0.004
Common Stock, Value, Issued	$77.078	$267.679	$275.289	$281.943
Additional Paid in Capital	$153,192.228	$169,156.374	$170,314.656	$175,544.81
Retained Earnings (Accumulated Deficit)	$-146,976.855	$-143,382.122	$-154,217.276	$-158,714.27
Accumulated Other Comprehensive Income (Loss), Net of Tax	$-182.801	$-282.159	$-246.137	$-255.798
Stockholders' Equity Attributable to Parent	$6,109.654	$25,759.776	$16,126.536	$16,856.689
Preferred Stock, Shares Authorized	10,000,000	10,000,000	10,000,000	10,000,000
Common Stock, Shares Authorized	50,000,000	150,000,000	150,000,000	150,000,000
Common Stock, Shares, Issued	7,705,640	3,000,788	3,761,739	4,427,167

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$-12,513.896	$3,594.733	$-10,835.154	$-10,986.709
Net Cash Provided by (Used in) Operating Activities	$-9,556.951	$8,559.115	$-9,961.176	$-8,506.81
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$36.02	$-57.231	$173.634	$35.445
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-3,554.865	$1,337.428	$4,904.758	$6,048.456
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$2,458.951	$3,796.379	$8,701.137	$15,886.078
Depreciation, Depletion and Amortization	$51.798	$19.205	$24.801	$42.364
Payments to Acquire Property, Plant, and Equipment	—	$6.256	$110.789	$107.068
Impairment of Intangible Assets, Finite-lived	—	$104.167	$0	$0
Payments to Acquire Debt Securities, Available-for-sale	—	$35,632.375	$8,175.851	$9,122.681
Proceeds from Sale of Debt Securities, Available-for-sale	—	$1,338.256	$305	$0
Share-based Payment Arrangement, Noncash Expense	$754.944	$656.593	$900.236	$807.666
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale	—	$11,637.764	$22,408.285	$18,831.285
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)	$1,904.314	$2,008	$4,624	$4,624
Net Cash Provided by (Used in) Investing Activities	$0	$-22,662.611	$14,426.645	$9,601.536
Accretion (Amortization) of Discounts and Premiums, Investments	—	$283.474	$112.305	$21.907
Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss	—	$4.519	$2.371	$0.617
Deferred Income Taxes and Tax Credits	$90.319	$-288.75	$-388.538	$-388.538
Gain (Loss) on Disposition of Assets	$-28.379	$-3.76	$0	$0
Proceeds from Issuance of Private Placement	$115.715	$14,998.865	$0	$4,999.848
Payments of Stock Issuance Costs	—	—	$0	$71.701
Proceeds from Warrant Exercises	$307.079	$1,689.339	$265.655	$0.466
Proceeds from Lines of Credit	—	—	$2,750	$1,750
Net Cash Provided by (Used in) Financing Activities	$5,966.066	$15,498.155	$265.655	$4,918.285
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	$114.747	$0	$336.507	$53.572
Increase (Decrease) in Prepaid Expense and Other Assets	$-0.885	$1,823.897	$-419.736	$162.067
Increase (Decrease) in Accounts Receivable	—	$601.197	$921.573	$-1,326.636
Increase (Decrease) in Income Taxes Receivable	$548.109	$-1,634.464	$1,493.27	$1,493.27
Increase (Decrease) in Other Operating Assets	$7.583	$-15.231	$34.172	$23.493
Increase (Decrease) in Accounts Payable	$-808.016	$226.119	$1,124.928	$-66.169
Increase (Decrease) in Accrued Liabilities	$-459.713	$3,280.73	$-2,337.649	$-611.534
IncreaseDecreaseInOperatingLeaseLiability	$0.584	$-46.5	$-103.845	$-147.673
Increase (Decrease) in Contract with Customer, Liability	—	—	$1,250	$0

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("KPRX","financials")

Full statements spill as a table. For one cell: =jivedata("KPRX","Revenue") or =jivedata("KPRX","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.